Clinical Trial Update: TYPE 2 HEPATORENAL SYNDROME [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the safety and efficacy of terlipressin plus norepinephrine for Type 2 hepatorenal syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatorenal Syndrome

Drugs mentioned

• NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)
• Terlipressin (terlipressin)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Safety and Efficacy of Terlipressin and Noradrenaline and Predictive Factors of Response in Type 2 HRS | Phase 3 | Status: COMPLETED